{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:54:50Z","timestamp":1761512090511},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.idc.2004.11.004","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T19:48:10Z","timestamp":1113508090000},"page":"151-168","source":"Crossref","is-referenced-by-count":72,"title":["Yellow fever and Japanese encephalitis vaccines: indications and complications"],"prefix":"10.1016","volume":"19","author":[{"given":"Anthony A.","family":"Marfin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S. Barwick","family":"Eidex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis E.","family":"Kozarsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Cetron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2004.11.004_bib1","series-title":"District guidelines for yellow fever surveillance. Yellow fever technical consensus meeting. Geneva, March 2\u20133, 1998. WHO\/EPI\/GEN\/98.08, 1\u201325","author":"WHO","year":"1998"},{"key":"10.1016\/j.idc.2004.11.004_bib2","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever","author":"Monath","year":"2004"},{"key":"10.1016\/j.idc.2004.11.004_bib3","series-title":"Health information for international travel 2003\u20132004","author":"Centers for Disease Control and Prevention","year":"2003"},{"key":"10.1016\/j.idc.2004.11.004_bib4","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2004.11.004_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cimid.2004.03.013","article-title":"The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?","volume":"27","author":"Gubler","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2004.11.004_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(99)00155-5","article-title":"Facing up to re-emergence of urban yellow fever","volume":"353","author":"Monath","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0035-9203(89)90518-X","article-title":"Urban yellow fever epidemic in western Nigeria, 1987","volume":"83","author":"Nasidi","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2004.11.004_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(05)65392-5","article-title":"Jungle yellow fever in the central Amazon","volume":"348","author":"Barros","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib9","first-page":"324","article-title":"Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2004.11.004_bib10","first-page":"303","article-title":"Fatal yellow fever in a traveler returning from Venezuela, 1999","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2004.11.004_bib11","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1086\/344180","article-title":"A Belgian traveler who acquired yellow fever in the Gambia","volume":"35","author":"Colebunders","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.11.004_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/516111","article-title":"Imported yellow fever in a United States citizen","volume":"25","author":"McFarland","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.11.004_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1997.0056","article-title":"Yellow fever vaccines","volume":"25","author":"Barrett","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.idc.2004.11.004_bib14","series-title":"Yellow fever vaccination. WHO Monograph Series, Number 30","author":"Smithburn","year":"1956"},{"key":"10.1016\/j.idc.2004.11.004_bib15","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0264-410X(01)00439-X","article-title":"Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing","volume":"20","author":"Pugachev","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2004.11.004_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.1045","article-title":"Comparison of the immunogenicity and safety of two 17D yellow fever vaccines","volume":"60","author":"Lang","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2004.11.004_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2004.11.004_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.idc.2004.11.004_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.idc.2004.11.004_bib20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0091-6749(93)90344-F","article-title":"Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin","volume":"91","author":"Kelso","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.idc.2004.11.004_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0264-410X(97)00152-7","article-title":"Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines","volume":"16","author":"Sakaguchi","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2004.11.004_bib22","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/S0264-410X(98)00368-5","article-title":"Specific IgG to gelatin in children with systemic immediate- and nonimmediate-type reactions to measles, mumps and rubella vaccines","volume":"17","author":"Miyazawa","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2004.11.004_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib24","first-page":"989","article-title":"Adverse events associated with 17D-derived yellow fever vaccination\u2014United States, 2001\u20132002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2004.11.004_bib25","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.idc.2004.11.004_bib26","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2004.11.004_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil","volume":"290","author":"Galler","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.idc.2004.11.004_bib30","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(01)06914-8","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Adhiyaman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib31","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(01)06916-1","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Troillet","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib32","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(01)06917-3","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Werfel","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib33","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.idc.2004.11.004_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2004.11.004_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1708-8305.1999.tb00839.x","article-title":"GeoSentinel: the global emerging infections sentinel network of the International Society of Travel Medicine","volume":"6","author":"Freedman","year":"1999","journal-title":"J Travel Med"},{"key":"10.1016\/j.idc.2004.11.004_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14712598.4.4.559","article-title":"Thymosins: chemistry and biological properties in health and disease","volume":"4","author":"Goldstein","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.idc.2004.11.004_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ni1033","article-title":"Age-related changes in lymphocyte development and function","volume":"5","author":"Linton","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.idc.2004.11.004_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jcp.56.1.12","article-title":"What is Good's syndrome? Immunological abnormalities in patients with thymoma","volume":"56","author":"Kelleher","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.idc.2004.11.004_bib39","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2004.11.004_bib40","first-page":"237","article-title":"A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic","volume":"73","author":"Gajanana","year":"1995","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.idc.2004.11.004_bib41","series-title":"Vaccines","first-page":"919","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2004"},{"key":"10.1016\/j.idc.2004.11.004_bib42","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMra030476","article-title":"Flavivirus encephalitis","volume":"351","author":"Solomon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2004.11.004_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travelers: exploring the limits of risk","volume":"35","author":"Shlim","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.11.004_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0404.1997.tb00250.x","article-title":"Anterior horn cells are also involved in Japanese encephalitis","volume":"96","author":"Misra","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.idc.2004.11.004_bib45","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(97)07509-0","article-title":"Poliomyelitis-like illness due to Japanese encephalitis virus","volume":"351","author":"Solomon","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2004.11.004_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/infdis\/165.4.631","article-title":"Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus","volume":"165","author":"Hoke","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.11.004_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.idc.2004.11.004_bib48","series-title":"Travelers' vaccines","first-page":"219","article-title":"Vaccines against Japanese encephalitis","author":"Solomon","year":"2004"},{"key":"10.1016\/j.idc.2004.11.004_bib49","first-page":"1","article-title":"Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"42","author":"Tsai","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2004.11.004_bib50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0889-8561(03)00102-4","article-title":"Allergic reactions to Japanese encephalitis vaccine","volume":"23","author":"Plesner","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.idc.2004.11.004_bib51","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","article-title":"Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants","volume":"161","author":"Poland","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.11.004_bib52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.1947.02880050001001","article-title":"Epidemic encephalitis in military personnel","volume":"133","author":"Sabin","year":"1947","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2004.11.004_bib53","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0264-410X(99)00403-X","article-title":"Case-control study of allergic reactions to Japanese encephalitis vaccine","volume":"18","author":"Plesner","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2004.11.004_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0887-8994(92)90036-X","article-title":"Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination","volume":"8","author":"Ohtaki","year":"1992","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.idc.2004.11.004_bib55","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jnnp.59.3.316","article-title":"Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains)","volume":"59","author":"Ohtaki","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.idc.2004.11.004_bib56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1468-1331.1998.550479.x","article-title":"Neurological complications to vaccination against Japanese encephalitis","volume":"5","author":"Plesner","year":"1998","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.idc.2004.11.004_bib57","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2004.11.004_bib58","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.vaccine.2003.10.001","article-title":"Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination","volume":"22","author":"Konishi","year":"2004","journal-title":"Vaccine"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552004001382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552004001382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T09:56:10Z","timestamp":1550051770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552004001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0891552004001382"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2004.11.004","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}